277 related articles for article (PubMed ID: 15988670)
21. Insulin therapy in NWFP Pakistan.
Ahmad M
J Ayub Med Coll Abbottabad; 2001; 13(3):36-7. PubMed ID: 11873397
[No Abstract] [Full Text] [Related]
22. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
Moodie P
N Z Med J; 2006 Jun; 119(1236):U2040. PubMed ID: 16807582
[No Abstract] [Full Text] [Related]
23. [Short acting insulin analogues for type 2 diabetes. Unnecessary additional expenditure or valuable added benefit? Interview by Böhm Sanja].
Hess R; Kerner W
Dtsch Med Wochenschr; 2006 Oct; Suppl 1():36-7. PubMed ID: 17595817
[No Abstract] [Full Text] [Related]
24. Economics of insulin.
Shah SN
J Assoc Physicians India; 2007 Jul; 55 Suppl():67-70. PubMed ID: 17927015
[No Abstract] [Full Text] [Related]
25. [Epidemiology of diabetes in the South Moravian region].
Rezler D
Vnitr Lek; 1968 Sep; 14(10):937-45. PubMed ID: 5684132
[No Abstract] [Full Text] [Related]
26. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
27. Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia.
Ali M; White J; Lee CH; Palmer JL; Smith-Palmer J; Fakhoury W; Valentine WJ
J Med Econ; 2008; 11(4):651-70. PubMed ID: 19450074
[TBL] [Abstract][Full Text] [Related]
28. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
29. Diabetes in Malaysia: problems and challenges.
Embong M
Med J Malaysia; 1990 Mar; 45(1):1-7. PubMed ID: 2152062
[No Abstract] [Full Text] [Related]
30. [Diabetes in Spain. Analysis of prevalence and medical care by the use of drugs and self-care materials].
Figuerola D; Castell C; Lloveras G
Med Clin (Barc); 1988 Oct; 91(11):401-5. PubMed ID: 3067004
[No Abstract] [Full Text] [Related]
31. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system.
Gellad W; Mor M; Zhao X; Donohue J; Good C
Arch Intern Med; 2012 Nov; 172(20):1608-9. PubMed ID: 23044980
[No Abstract] [Full Text] [Related]
32. [Current cost analysis in the management of diabetes mellitus].
Oberender P
Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S110-4; discussion S124-6. PubMed ID: 18686219
[TBL] [Abstract][Full Text] [Related]
33. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
Rathmann W; Haastert B; Icks A; Giani G
Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacoeconomy of diabetes mellitus--trends in the Czech Republic].
Horák P
Vnitr Lek; 2009 Apr; 55(4):331-40. PubMed ID: 19449745
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
[TBL] [Abstract][Full Text] [Related]
36. [Insulin. A comparison of commercial preparations].
Menz W
Med Monatsschr Pharm; 2006 Mar; 29(3):97-100. PubMed ID: 16550883
[No Abstract] [Full Text] [Related]
37. Diabetes: prevalence and economic implications.
Manag Care; 2000 Aug; 9(8 Suppl):2-4. PubMed ID: 11729414
[No Abstract] [Full Text] [Related]
38. [The first inhalational insulin. Which patients really profit from it? (interview by Dr. D. Einecke)].
Schumm-Draeger PM
MMW Fortschr Med; 2007 Jan; 149(1-2):16-7. PubMed ID: 17632858
[No Abstract] [Full Text] [Related]
39. Direct health care costs of diabetic patients in Spain.
Oliva J; Lobo F; Molina B; Monereo S
Diabetes Care; 2004 Nov; 27(11):2616-21. PubMed ID: 15504995
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
